Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa

BACKGROUND: Respiratory syncytial virus (RSV) causes a substantial burden of acute lower respiratory infection in children under 5 years, particularly in low- and middle-income countries (LMICs). Maternal vaccine (MV) and next-generation monoclonal antibody (mAb) candidates have been shown to reduce...

Descripción completa

Detalles Bibliográficos
Autores principales: Koltai, Mihaly, Moyes, Jocelyn, Nyawanda, Bryan, Nyiro, Joyce, Munywoki, Patrick K., Tempia, Stefano, Li, Xiao, Antillon, Marina, Bilcke, Joke, Flasche, Stefan, Beutels, Philippe, Nokes, D. James, Cohen, Cheryl, Jit, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064962/
https://www.ncbi.nlm.nih.gov/pubmed/37004062
http://dx.doi.org/10.1186/s12916-023-02806-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064962/
https://www.ncbi.nlm.nih.gov/pubmed/37004062
http://dx.doi.org/10.1186/s12916-023-02806-w

Ejemplares similares